Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium
Authors:
- Facundo Vitelli-StorelliFVFacundo Vitelli-Storelli
- María Rubín-GarcíaMRMaría Rubín-García
- Claudio PelucchiCPClaudio Pelucchi
- Yolanda BenaventeYBYolanda Benavente
- Rossella BonziRBRossella Bonzi
- Matteo RotaMatteo Rota
- Domenico PalliDPDomenico Palli
- Monica FerraroniMFMonica Ferraroni
- Nuno LunetNuno Lunet
- Samantha MoraisSMSamantha Morais
- Weimin YeWYWeimin Ye
- Amelie PlymothAPAmelie Plymoth
Open Access
Abstract
Although there is a clear relationship between family history (FH) and the risk of gastric cancer (GC), quantification is still needed in relation to different histological types and anatomical sites, and in strata of covariates. The objective was to analyze the risk of GC according to first-degree FH in a uniquely large epidemiological consortium of GC. This investigation includes 5946 cases and 12,776 controls from 17 studies of the Stomach Cancer Pooling (StoP) Project consortium. Summary odds ratios (OR) and the corresponding 95% confidence intervals (CIs) were calculated by pooling study-specific ORs using fixed-effect model meta-analysis techniques. Stratified analyses were carried out by sex, age, tumor location and histological type, smoking habit, socioeconomic status, alcohol intake and fruit consumption. The pooled OR for GC was 1.84 (95% CI: 1.64–2.04; I2 = 6.1%, P heterogeneity = 0.383) in subjects with vs. those without first-degree relatives with GC. No significant differences were observed among subgroups of sex, age, geographic area or study period. Associations tended to be stronger for non-cardia (OR = 1.82; 95% CI: 1.59–2.05 for subjects with FH) than for cardia GC (OR = 1.38; 95% CI: 0.98–1.77), and for the intestinal (OR = 1.92; 95% CI: 1.62–2.23) than for the diffuse histotype (OR = 1.62; 95% CI: 1.28–1.96). This analysis confirms the effect of FH on the risk of GC, reporting an approximately doubled risk, and provides further quantification of the risk of GC according to the subsite and histotype. Considering these findings, accounting for the presence of FH to carry out correct prevention and diagnosis measures is of the utmost importance.Keywords
This publication has 40 references indexed in Scilit:
- History, Pathogenesis, and Management of Familial Gastric Cancer: Original Study of John XXIII's FamilyBioMed Research International, 2012
- A case–control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progressionBMC Cancer, 2012
- Dietary habits and gastric cancer risk in north-west IranCancer Causes & Control, 2011
- Family history and the risk of gastric cancerBritish Journal of Cancer, 2009
- Overweight, obesity and gastric cancer risk: Results from a meta-analysis of cohort studiesEuropean Journal of Cancer, 2009
- Gastric cancer mortality trends in Spain, 1976-2005, differences by autonomous region and sexBMC Cancer, 2009
- Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpressionCancer Causes & Control, 2008
- Family history of cancer and stomach cancer riskInternational Journal of Cancer, 2008
- Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in JapanGastric Cancer, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003